ILMN
$ILMN
Illumina, Inc.
Leading genomic sequencing and DNA microarray technology company advancing precision medicine.
Healthcare$126.59
+3.64 (+2.96%)
Day Range$121.54 - $127.41
Prev Close$122.95
Analyst Rating
Buy
15 Buy / 10 Hold / 3 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
ILMN: Genomics partnership lifts prospects, valuation in balance
Illumina ($ILMN) shows renewed momentum after a Regeneron alliance and a large genomics-proteomics dataset, but the stock trades well below its 52-week high and faces execution and valuation questions.
Mar 16, 2026